Mays Cancer Center experts to discuss why getting screenings now is important during May 29 webinar SAN ANTONIO (May 22, 2020) — Studies have shown that individuals with cancer who get COVID-19 are more likely to have poor outcomes. And with everyone staying home during the pandemic, many people have missed their regular cancer screenings. […]
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
UT Health San Antonio, University Hospital begin second phase of clinical trial for promising COVID-19 drugMay 13, 2020
Media contact: Rosanne Fohn, (210) 567-3026, firstname.lastname@example.org SAN ANTONIO (May 11, 2020) — The COVID-19 Infectious Disease team at UT Health San Antonio and University Health System is beginning the second stage of the remdesivir clinical trial, which is being sponsored by the National Institute of Allergy and Infectious Diseases, NIAID. This second phase of […]
Asante Sebastian Contreras, age 20, and a student in the Department of Emergency Health Sciences Paramedic Certification Program at UT Health San Antonio, died in a traffic crash on Sunday, May 3, in San Antonio. Contreras worked as an emergency medical technician for an ambulance service in San Antonio and, as a student in the […]
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 in a randomized clinical trial.
FDA gives emergency authorization to COVID-19 drug being tested by UT Health San Antonio, University HospitalMay 2, 2020
SAN ANTONIO (May 1, 2020) — The FDA on May 1 gave emergency authorization to a new anti-viral drug to treat patients with COVID-19. The announcement was made during an afternoon news conference by President Trump. It comes two days after the National Institute of Allergy and Infectious Diseases (NIAID) released preliminary results of a […]